Bryce Jackson, MD
Obstetrics & Gynecology · Panama City, FLNPI 1467423632
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 60.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2021 at $215 and has fallen 80.9% since, to $41 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in FL, where the typical reported total is $820.
Across 25 payments — averaging $26.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$396
- Organon$70
- Pfizer$34
- Johnson & Johnson$32
- Bayer$32
- Shield Therapeutics Inc$22
- plus $69 from 4 others
What the payments were for
- Food & beverage$61794%
- Education$396%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $396 |
| Organon | 3 | $70 |
| Pfizer | 2 | $34 |
| Johnson & Johnson | 2 | $32 |
| Bayer | 1 | $32 |
| Shield Therapeutics Inc | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Exact Sciences | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Merck | 1 | $13 |
How this compares
$656 in reported general payments places this provider in the 45th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Medroxyprogesterone Acetate | 11 | $268 |
| Alendronate Sodium | 38 | $134 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Panama City
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
- Scott JordanFort Lauderdale$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.